
Phibro Animal Health fell 23.6% from $45.33 to $34.64, behind the S&P 500's +9.8%. Its worst day was May 7 (−26.2%), and its low came Jun 2 at $28.40.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.87 beat the $0.68 estimate on $373.9M revenue (est. $356.2M); FY revenue guidance of $1.4B–$1.5B against the $1.5B consensus.
+22.0%, the year's best day · S&P 500 −1.2%
Story events cover the past 12 months · Times ET
Phibro Animal Health closed at its highest level of the year, 31.4% above where the year started.
+2.9% · S&P 500 +1.0%
EPS of $0.76 beat the $0.71 estimate on $383.5M revenue (est. $365.8M); FY revenue guidance of $1.5B–$1.5B against the $1.5B consensus.
−26.2%, the year's worst day, on 2M shares, the year's heaviest volume · S&P 500 −0.3%
Phibro Animal Health closed at its lowest level of the year, 37.3% below where the year started.
−4.9% · S&P 500 +0.1%
EPS of $0.85 beat the $0.72 estimate on $396.7M revenue (est. $375.9M); FY revenue guidance of $1.6B–$1.6B against the $1.5B consensus.
+0.7% · S&P 500 +0.7%
EPS of $0.79 beat the $0.78 estimate on $386.8M revenue (est. $382.2M); FY revenue guidance of $1.6B–$1.6B against the $1.6B consensus.
−10.2% · S&P 500 −4.4%
Where it ended: a close of $34.64 on Nov 10, 2026. Up next: Q2 2027 earnings on Feb 3, 2027 (EPS est. $0.94, revenue est. $399.5M).
As of the Nov 10, 2026 close
Replay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PAHC and SPY from Benzinga historical bars. Not investment advice.